TY - JOUR
T1 - Pacemaker recovery after permanent pacemaker implantation post-transcatheter aortic valve implantation
T2 - A sub-study of the LANDMARK trial
AU - Tobe, Akihiro
AU - Smits, Pieter C
AU - van Royen, Niels
AU - Amat-Santos, Ignacio J
AU - Hudec, Martin
AU - Bunc, Matjaz
AU - Van den Branden, Ben J L
AU - Laanmets, Peep
AU - Unic, Daniel
AU - Merkely, Bela
AU - Hermanides, Renicus S
AU - Ninios, Vlasis
AU - Protasiewicz, Marcin
AU - Rensing, Benno J W M
AU - Martin, Pedro L
AU - Feres, Fausto
AU - Almeida, Manuel De Sousa
AU - van Belle, Eric
AU - Linke, Axel
AU - Ielasi, Alfonso
AU - Montorfano, Matteo
AU - Webster, Mark
AU - Toutouzas, Konstantinos
AU - Teiger, Emmanuel
AU - Bedogni, Francesco
AU - Voskuil, Michiel
AU - Pan, Manuel
AU - Angerås, Oskar
AU - Kim, Won-Keun
AU - Rothe, Jürgen
AU - Kristić, Ivica
AU - Peral, Vicente
AU - Garg, Scot
AU - Versteeg, Geert A A
AU - Gómez, Mario García
AU - Tsai, Tsung-Ying
AU - Thakkar, Ashokkumar
AU - Chandra, Udita
AU - Morice, Marie-Claude
AU - Onuma, Yoshinobu
AU - Baumbach, Andreas
AU - Serruys, Patrick W
N1 - Publisher Copyright:
© 2026 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license. http://creativecommons.org/licenses/by/4.0/
PY - 2026/8/1
Y1 - 2026/8/1
N2 - BACKGROUND: Conduction system disturbances resulting in permanent pacemaker implantation (PPI) are common complications after transcatheter aortic valve implantation (TAVI). In some patients, there is delayed recovery of the conduction system post-procedure. This study aims to report the incidence and predictors of ventricular pacing (VP) rate≦1% at 1 year after TAVI.METHODS: This is a post-hoc sub-study of the LANDMARK multicentre trial, which randomized 768 patients in a 2:1:1 ratio to the Myval (n = 384) transcatheter heart valve (THV) series or contemporary THVs (Sapien [n = 192] and Evolut [n = 192] series) for the treatment of severe aortic stenosis. Overall, 122 (15.9%) patients underwent PPI within 30 days after TAVI, and 1-year pacemaker follow-up data were retrospectively collected in 99 patients. Pacemaker recovery (PMR) was defined as a VP rate ≦1% at follow-up.RESULTS: PMR occurred in 18% (18/99) of patients. The PMR group was younger than the non-PMR group (78.6 ± 3.0 vs 81.1 ± 5.1 years, p = 0.045). Implantation depth under the non-coronary cusp did not differ between groups (5.7 ± 3.5 vs 5.8 ± 2.8 mm, p = 0.94). There were no significant differences in PMR rates based on THV type: Myval 25% (11/44), Sapien 19% (5/27), and Evolut 7% (2/28) (p = 0.16). In multivariable logistic regression, atrial fibrillation was associated with lower odds of PMR (odds ratio 0.09, 95% confidence interval 0.00-0.77, p = 0.02.CONCLUSIONS: At 1 year, conduction system recovery (VP≦1%) was observed in 18% of patients who underwent PPI after TAVI, with no significant difference among the Myval, Sapien and Evolut series. Atrial fibrillation was associated with lower odds of recovery.
AB - BACKGROUND: Conduction system disturbances resulting in permanent pacemaker implantation (PPI) are common complications after transcatheter aortic valve implantation (TAVI). In some patients, there is delayed recovery of the conduction system post-procedure. This study aims to report the incidence and predictors of ventricular pacing (VP) rate≦1% at 1 year after TAVI.METHODS: This is a post-hoc sub-study of the LANDMARK multicentre trial, which randomized 768 patients in a 2:1:1 ratio to the Myval (n = 384) transcatheter heart valve (THV) series or contemporary THVs (Sapien [n = 192] and Evolut [n = 192] series) for the treatment of severe aortic stenosis. Overall, 122 (15.9%) patients underwent PPI within 30 days after TAVI, and 1-year pacemaker follow-up data were retrospectively collected in 99 patients. Pacemaker recovery (PMR) was defined as a VP rate ≦1% at follow-up.RESULTS: PMR occurred in 18% (18/99) of patients. The PMR group was younger than the non-PMR group (78.6 ± 3.0 vs 81.1 ± 5.1 years, p = 0.045). Implantation depth under the non-coronary cusp did not differ between groups (5.7 ± 3.5 vs 5.8 ± 2.8 mm, p = 0.94). There were no significant differences in PMR rates based on THV type: Myval 25% (11/44), Sapien 19% (5/27), and Evolut 7% (2/28) (p = 0.16). In multivariable logistic regression, atrial fibrillation was associated with lower odds of PMR (odds ratio 0.09, 95% confidence interval 0.00-0.77, p = 0.02.CONCLUSIONS: At 1 year, conduction system recovery (VP≦1%) was observed in 18% of patients who underwent PPI after TAVI, with no significant difference among the Myval, Sapien and Evolut series. Atrial fibrillation was associated with lower odds of recovery.
U2 - 10.1016/j.ijcard.2026.134525
DO - 10.1016/j.ijcard.2026.134525
M3 - Article
C2 - 42044716
SN - 0167-5273
VL - 456
JO - International Journal of Cardiology
JF - International Journal of Cardiology
M1 - 134525
ER -